Current Concepts in the Use of Dual-Mobility Constructs for Primary and Revision THA

High-Yield Summary

• Dual-mobility (DM) constructs combine a small femoral head articulating within a large polyethylene liner that moves within a metal acetabular shell, enhancing stability and reducing dislocation risk in primary and revision total hip arthroplasty (THA).
• DM implants are particularly advantageous in patients at high risk for instability: elderly, neuromuscular disorders, revision cases, and those with abductor deficiency.
• The primary indication for DM use is prevention and treatment of instability; however, concerns about polyethylene wear and intraprosthetic dislocation (IPD) remain critical considerations.
• Surgical technique must ensure proper component positioning and soft tissue tensioning to maximize DM benefits and minimize complications.
• Recent evidence supports DM constructs as a standard option in revision THA for instability and increasingly in primary THA for high-risk patients, with evolving data on long-term survivorship.

Clinical Fundamentals

Relevant Anatomy and Biomechanics

The hip joint’s stability depends on osseous congruity, capsuloligamentous structures, and dynamic muscular control. The native acetabulum’s deep socket and labrum provide containment, while the abductor mechanism maintains joint centration during gait.

Dual-mobility implants replicate this by introducing a dual articulation: a small femoral head (22-28 mm) articulates inside a large polyethylene liner, which itself articulates within a metal shell. This design increases the effective head size, improving the jump distance and range of motion before impingement or dislocation.

Epidemiology

Dislocation rates after primary THA range from 0.5% to 5%, but rise to 10-28% in revision settings. Risk factors include neuromuscular disease, abductor insufficiency, prior instability, and component malposition. DM constructs address this by mechanically reducing dislocation risk, especially in high-risk cohorts.

Classification & Diagnosis

Diagnostic Pearls

• Radiographs must be scrutinized for component position and signs of loosening or osteolysis.
• CT scans aid in assessing acetabular bone stock and cup version, essential for planning DM implantation.
• Beware of subtle intraprosthetic dislocation, which may present with groin pain and limited motion but normal radiographs; advanced imaging or intraoperative assessment may be necessary.

Decision-Making Algorithm

Rationale: Non-operative management is limited to stable hips without risk factors. DM constructs are favored when instability risk is elevated due to their biomechanical advantage. Surgical approach (posterior vs. direct anterior) is less critical than component positioning and soft tissue management in DM cases.

Surgical Mastery & Pearls

Step-by-Step Conceptual Overview

1. Preoperative Planning:

• Assess bone stock and soft tissue quality via imaging.
• Select DM implant size ensuring compatibility with femoral stem and acetabular shell.

2. Exposure and Component Removal (Revision):
• Preserve abductor musculature and capsule when possible.
• Remove loose components carefully to avoid further bone loss.

3. Acetabular Preparation:
• Ream to achieve a hemispherical, congruent bed.
• Position cup within Lewinnek safe zone to minimize impingement and IPD risk.

4. Trialing:
• Use trial DM liners to assess stability through full range of motion.
• Confirm absence of impingement and adequate soft tissue tension.

5. Implantation:
• Secure acetabular shell with appropriate fixation (screws, augments as needed).
• Insert DM polyethylene liner ensuring proper seating and locking mechanism engagement.
• Implant femoral head and reduce hip carefully.

6. Closure:
• Repair capsule and abductors meticulously to enhance stability.
• Avoid excessive soft tissue tension that may cause liner dissociation.

Intraoperative Red Flags

• Difficulty seating the DM liner may indicate mismatch or debris-do not force.
• Excessive anteversion or retroversion of the cup increases IPD risk.
• Inadequate soft tissue repair predisposes to instability despite DM use.
• Over-lengthening the limb can cause nerve stretch and patient dissatisfaction.

Evidence-Based Synthesis

Landmark randomized controlled trials and large registry analyses have demonstrated that DM constructs significantly reduce dislocation rates compared to conventional fixed-bearing implants in both primary and revision THA. A meta-analysis by De Martino et al. (2020) showed dislocation rates of 0.5-1.5% with DM versus 3-5% with standard implants in primary THA for high-risk patients.

In revision settings, registry data from the Australian Orthopaedic Association and the Nordic Arthroplasty Register indicate improved survivorship free from dislocation with DM liners, particularly in patients with abductor deficiency or prior instability.

However, concerns about polyethylene wear and intraprosthetic dislocation persist. Recent retrieval studies suggest modern highly cross-linked polyethylene liners reduce wear rates, but long-term data beyond 10 years remain limited. IPD, although rare (<1%), is a unique failure mode requiring awareness and prompt diagnosis.

Clinical consensus is evolving regarding the use of DM in routine primary THA for low-risk patients, with some advocating selective use based on patient-specific risk stratification rather than universal application.

Master Class Pro-Tip

Optimal outcomes with dual-mobility constructs hinge on a nuanced balance between maximizing jump distance and preserving soft tissue tension. Master surgeons recognize that meticulous restoration of native hip biomechanics-precise cup orientation within the Lewinnek safe zone, careful soft tissue repair, and avoidance of over-lengthening-prevents intraprosthetic dislocation and late instability. Intraoperative dynamic assessment of stability through full range of motion before final implantation is non-negotiable. Finally, integrating patient-specific risk factors with implant design choices transforms DM use from a fallback option into a proactive strategy for surgical excellence in both primary and revision THA.

Last Updated on April 29, 2026 by OrthoNet AI